Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm

Brain Research

Volumn 795, Issue 1-2, 1998, Pages 128-136

  Lamont, Elaine Waddington ^a   Kokkinidis, Larry ^b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF CANTERBURY   (New Zealand)

Author keywords

Amygdala; Dopamine D1 receptor; Fear potentiated startle; Mesoamygdaloid DA; Nucleus accumbens; SCH 23390

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONDITIONED REFLEX; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FEAR; MALE; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; STARTLE REFLEX; VENTRAL TEGMENTUM; ANIMAL; AUDITORY STIMULATION; CONDITIONING; DRUG ANTAGONISM; WISTAR RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ACOUSTIC STIMULATION; AMYGDALA; ANIMALS; CONDITIONING (PSYCHOLOGY); DOPAMINE ANTAGONISTS; FEAR; MALE; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; STARTLE REACTION;

EID: 0032496433     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00281-9     Document Type: Article

References (69)

1. J. Arnt, Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade, Acta Pharmacol. Toxicol. 51 (1982) 321-329.
2. J. Ashford, B.J. Jones, The effects of intra-amygdaloid injections of 6-hydroxydopamine on avoidance responding in rats, Br. J. Pharmacol. 56 (1976) 225-261.
3. J.R. Blackburn, J.G. Pfaus, A.G. Phillips, Dopamine functions in appetitive and defensive behaviors, Prog. Neurobiol. 39 (1992) 247-279.
4. D.C. Blanchard, R.J. Blanchard, Innate and conditioned reactions to threat in rats with amygdaloid lesions, J. Comp. Physiol. Psychol. 81 (1972) 281-290.
5. T.B. Borowski, L. Kokkinidis, Cocaine preexposure sensitizes conditioned fear in a potentiated acoustic startle paradigm, Pharmacol. Biochem. Behav. 49 (1994) 935-942.
6. T.B. Borowski, L. Kokkinidis, Contribution of ventral tegmental area dopamine neurons to expression of conditional fear: effects of electrical stimulation, excitotoxin lesions, and quinpirole infusion on potentiated startle in rats, Behav. Neurosci. 110 (1996) 1349-1364.
7. 1 receptor agonist SKF 38393 on fear extinction as measured with potentiated startle: implications for psychomotor stimulant psychosis, Behav. Neurosci., 1997, in press.
8. 2 subtypes of dopamine receptors in rat brain, J. Neurosci. 6 (1986) 3177-3188.
9. W.H. Bridger, I.J. Mandel, The effects of dimethoxyphenylethylamine and mescaline on classical conditioning in rats as measured by the potentiated startle response, Life Sci. 6 (1967) 775-781.
10. 1 antagonist SCH 23390 microinjected into the accumbens, amygdala or striatum on cocaine self-administration in the rat, Brain Res. 692 (1995) 47-56.
11. G.D. Carr, N.M. White, The relationship between stereotypy and memory improvement produced by amphetamine, Psychopharmacology 82 (1984) 203-209.
12. P.F. Chapman, E.W. Kairiss, C.L. Keenan, T.H. Brown, Long-term synaptic potentiation in the amygdala, Synapse 6 (1990) 271-278.
13. M.L. Coco, C.M. Kuhn, T.D. Ely, C.D. Kilts, Selective activation of mesoamygdaloid dopamine neurons by conditioned stress: attenuation by diazepam, Brain Res. 590 (1992) 39-47.
14. 1 receptors by SCH 23390, Neuropharmacology 22 (1983) 1327-1329.
15. M. Davis, The role of the amygdala in conditioned fear, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 255-306.
16. M. Davis, W.A. Falls, S. Campeau, M. Kim, Fear-potentiated startle: a neural and pharmacological analysis, Behav. Brain Res. 58 (1993) 175-198.
17. 1 dopamine receptor in the rat brain: quantitative autoradiographic localization using an iodinated ligand, Neuroscience 26 (1988) 83-100.
18. A.Y. Deutch, S.Y. Tam, R.H. Roth, Footshock and conditioned stress increase 3,4 dihydroxyphenylacetic acid (DOPAC) in the ventral tegmental area but not the substantia nigra, Brain Res. 333 (1985) 143-146.
19. J.H. Fallon, D.A. Koziell, R.Y. Moore, Catecholamine innervation of the basal forebrain: II. Amygdala, suprarhinal cortex and entorhinal cortex, J. Comp. Neurol. 180 (1978) 509-532.
20. M. Fendt, M. Koch, H.-U. Schnitzler, Lesions of the central gray block conditioned fear as measured with the potentiated startle paradigm, Behav. Brain Res. 74 (1996) 127-134.
21. H.C. Fibiger, A.G. Phillips, A.P. Zis, Deficits in instrumental responding after 6-hydroxydopamine lesions of the nigro-neostriatal dopaminergic projection, Pharmacol. Biochem. Behav. 2 (1974) 87-96.
22. P.W. Frankland, J.S. Yeomans, Fear-potentiated startle and electrically evoked startle mediated by synapses in rostrolateral midbrain, Behav. Neurosci. 109 (1995) 669-680.
23. D. Gaffan, Amygdala and the memory of reward, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 471-483.
24. 1-containing neurons, J. Neurosci. 15 (1995) 8167-8176.
25. G.V. Goddard, Functions of the amygdala, Psychol. Bull. 62 (1964) 89-109.
26. L.E. Goldstein, A.M. Rasmusson, B.S. Bunney, R.H. Roth, Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat, J. Neurosci. 16 (1996) 4787-4798.
27. 3 receptor antagonists on responses to selective activation of mesolimbic dopaminergic pathways in the rat, Br. J. Pharmacol. 99 (1990) 227-232.
28. L. Heimer, G.F. Alheid, D.S. Zahm, Basal forebrain organization: an anatomical framework for motor aspects of drive and motivation, in: P.W. Kalivas, C.D. Barnes (Eds.), Limbic Motor Circuits and Neuropsychiatry, CRC Press, Boca Raton, FL, 1993, pp. 1-43.
29. 2+ conductance, J. Neurosci. 17 (1997) 3334-3342.
30. T.H. Hijzen, S.W. Houtzager, R.J.E. Joordens, B. Olivier, J.L. Slangen, Predictive validity of the potentiated startle response as a behavioral model for anxiolytic drugs, Psychopharmacology 118 (1995) 150-154.
31. J.M. Hitchcock, M. Davis, Efferent pathway of the amygdala involved in conditioned fear as measured with the fear-potentiated startle paradigm, Behav. Neurosci. 105 (1991) 826-842.
32. 1 antagonist, Eur. J. Pharmacol. 91 (1983) 153-154.
33. L.C. Iorio, A. Barnett, F.H. Leitz, V.P. Houser, C.A. Korduba, SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems, J. Pharmacol. Exp. Ther. 226 (1983) 462-468.
34. B.S. Kapp, P.J. Whalen, W.F. Supple, J.P. Pascoe, Amygdaloid contributions to conditioned arousal and sensory information processing, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 229-254.
35. M. Kim, S. Campeau, W.A. Falls, M. Davis, Infusion of the non-NMDA receptor antagonist CNQX into the amygdala blocks the expression of fear-potentiated startle, Behav. Neural Biol. 59 (1993) 5-8.
36. G.F. Koob, F.E. Bloom, Cellular and molecular mechanisms of drug dependence, Science 242 (1988) 715-723.
37. G.F. Koob, H. Simon, J.P. Herman, M. Le Moal, Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems, Brain Res. 303 (1984) 319-329.
38. J.E. LeDoux, Emotion and the amygdala, in: J.P. Aggleton (Ed.), The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction, Wiley-Liss, New York, 1992, pp. 339-351.
39. Y. Lee, D. Walker, M. Davis, Lack of a temporal gradient of retrograde amnesia following NMDA-induced lesions of the basolateral amygdala assessed with the fear-potentiated startle paradigm, Behav. Neurosci. 110 (1996) 836-839.
40. 1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat, Pharmacol. Biochem. Behav. 45 (1993) 239-242.
41. L.D. McCullough, J.D. Sokolowski, J.D. Salamone, A neurochemical and behavioral investigation of the involvement of nucleus accumbens dopamine in instrumental avoidance, Neuroscience 52 (1993) 919-925.
42. 2 dopamine receptor mRNAs in rat brain, Neuropsychopharmacology 5 (1991) 231-242.
43. J.S. Milner, Effects of D-amphetamine on acquisition of leverpress Sidman avoidance in rats, Physiol. Psychol. 2 (1974) 392-396.
44. M.J.D. Miserendino, C.B. Sananes, K.R. Melia, M. Davis, Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala, Nature 345 (1990) 716-718.
45. L.J. Munro, L. Kokkinidis, Infusion of quinpirole and muscimol into the ventral tegmental area inhibits fear-potentiated startle: implications for the role of dopamine in fear expression, Brain Res. 746 (1997) 231-238.
46. R.D. Oades, G.M. Halliday, Ventral tegmental (A10) system: neurobiology: 1. Anatomy and connectivity, Brain Res. Rev. 12 (1987) 117-165.
47. 5 dopamine receptor activation increases the magnitude of early long-term potentiation at CA1 hippocampal synapses, J. Neurosci. 16 (1996) 7478-7486.
48. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1986.
49. F. Petty, J. Mott, A.D. Sherman, Potential locus and mechanism of blockade of conditioned avoidance responding by neuroleptics, Neuropharmacology 23 (1984) 73-78.
50. A.G. Phillips, H.C. Fibiger, Anatomical and neurochemical substrates of drug reward determined by the conditioned place preference technique, in: M.A. Bozarth (Ed.), Methods of Assessing the Reinforcing Properties of Abused Drugs, Springer-Verlag, New York, 1987, pp. 275-290.
51. D. Quartermain, M.E. Judge, Retrieval enhancement in mice by pretest amphetamine injection after a long retention interval, Physiol. Psychol. 11 (1983) 166-172.
52. J.B. Rosen, J.M. Hitchcock, C.B. Sananes, M.J.D. Miserendino, M. Davis, A direct projection from the central nucleus of the amygdala to the acoustic startle pathway: anterograde and retrograde tracing studies, Behav. Neurosci. 105 (1991) 817-825.
53. 1 receptor antagonist, on operant and avoidance behavior in rats, Pharmacol. Biochem. Behav. 26 (1987) 509-513.
54. B. Scatton, M. D'Angio, P. Driscoll, A. Serrano, An in vivo voltammetric study of the response of mesocortical and mesoaccumbens dopaminergic neurons to environmental stimuli in strains of rats with differing levels of emotionality, Ann. New York Acad. Sci. 537 (1988) 124-137.
55. 2 dopamine receptors in the amygdaloid nuclear complex of the rat brain, Synapse 11 (1992) 146-154.
56. A.D. Sherman, F. Petty, J.L. Sacquitne, Regional aspects of the delay of acquisition conditioned avoidance responding by chlorpromazine, Life Sci. 30 (1982) 1811-1815.
57. L. Stein, J.D. Belluzzi, Cellular investigations of behavioral reinforcement, Neurosci. Biobehav. Rev. 13 (1989) 69-80.
58. L.W. Swanson, The projections of the ventral tegmental area and adjacent regions: a combined fluorescent retrograde tracer and immunofluorescence study in the rat, Brain Res. Bull. 9 (1982) 321-353.
59. N.R. Swerdlow, D.L. Braff, M.A. Geyer, GABAergic projection from nucleus accumbens to ventral pallidum mediates dopamine-induced sensorimotor gating deficits of acoustic startle in rats, Brain Res. 532 (1990) 146-150.
60. M.L. Wadenberg, E. Ericson, O. Magnusson, S. Ahlenius, Suppression of conditioned avoidance behavior by the local application of (-)-sulpiride into the ventral, but not the dorsal, striatum of the rat, Biol. Psychiatry 28 (1990) 297-307.
61. 2 receptor systems, Biochem. Pharmacol. 35 (1986) 3661-3667.
62. 2 agonist effects, Science 236 (1987) 719-722.
63. Z. Wang, G.V. Rebec, Amygdaloid neurons respond to clozapine rather than haloperidol in behaving rats pretreated with intra-amygdaloid amphetamine, Brain Res. 711 (1996) 64-72.
64. L. Weiskrantz, Behavioral changes associated with ablation of the amygdaloid complex in monkeys, J. Comp. Physiol. Psychol. 49 (1956) 381-391.
65. B.H.C. Westerink, H.-F. Kwint, J.B. deVries, The pharmacology of mesolimbic dopamine neurons: a dual-probe microdialysis study in the ventral tegmental area and nucleus accumbens of the rat brain, J. Neurosci. 16 (1996) 2605-2611.
66. F.J. White, R.Y. Wang, Pharmacological characterization of dopamine autoreceptors in the rat ventral tegmental area: microion-tophoretic studies, J. Pharmacol. Exp. Ther. 231 (1984) 275-280.
67. M.L. Willick, L. Kokkinidis, Cocaine enhances the expression of fear-potentiated startle: evaluation of state-dependent extinction and the shock-sensitization of acoustic startle, Behav. Neurosci. 109 (1995) 929-938.
68. R.A. Wise, D.C. Hoffman, Localization of drug reward mechanisms by intracranial injections, Synapse 10 (1992) 247-263.
69. A.P. Zis, H.C. Fibiger, A.G. Phillips, Reversal by L-dopa of impaired learning due to destruction of the dopaminergic nigro-neostriatal projection, Science 185 (1974) 960-962.